Latest News and Press Releases

Transaction proceeds will be used to fund the further development of the MosaiQ platform beyond the Donor Lab and the commercial launch of MosaiQ JERSEY, Channel Islands, May 24, 2021 (GLOBE...

JERSEY, Channel Islands, April 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized...

Encouraging results from a study of its MosaiQ™ multiplex molecular disease screening (MDS) MicroarrayMDS product progressing through developmentUpdate regarding progress on the Company's MosaiQ...

JERSEY, Channel Islands, March 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards...

JERSEY, Channel Islands, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the Company will present at the...

JERSEY, Channel Islands, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed...

JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...

MosaiQ COVID-19 semi-quantitative antibody test CE markedExpanded MosaiQ IH microarray EU launch planned for fourth quarter CY2021Sales of Alba by Quotient reagents exceed guidanceStrong cash position...

JERSEY, Channel Islands, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter...

JERSEY, Channel Islands, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the...